The U.S. Should Strengthen Its Science And Technology Links With Latin America

Latin America is experiencing a prolonged economic crisis that is eroding its science and technology base. The burden of a $400 billion foreign debt has forced deep cuts in government spending on research and development, and drastically devalued currencies have made it prohibitively expensive for scientists to travel abroad, buy foreign-made equipment, and subscribe to international journals. We should recognize the United States’ role in this and other Latin American problems. Our ban

Written byEugene Garfield
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Latin America is experiencing a prolonged economic crisis that is eroding its science and technology base. The burden of a $400 billion foreign debt has forced deep cuts in government spending on research and development, and drastically devalued currencies have made it prohibitively expensive for scientists to travel abroad, buy foreign-made equipment, and subscribe to international journals.

We should recognize the United States’ role in this and other Latin American problems. Our banks’ desire for easy profits is partly to blame for the region’s debt crisis. And our society’s insatiable appetite for drugs has fostered the cocaine cartels that corrupt Colombia, Bolivia, and Peru. Will our government’s concern over the federal budget deficit allow the continued deterioration of Latin American science?

An answer to this question will come from Congress’ action on a bill (H.R. 2152) introduced by Rep. Robert A. Roe (D-NJ.), chairman of the House Science, Space, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies